Detalhe da pesquisa
1.
PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests".
New Microbiol
; 47(1): 116-122, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38700893
2.
Primary Cutaneous Cryptococcosis in an Immunocompetent Patient: Diagnostic Workflow and Choice of Treatment.
Diagnostics (Basel)
; 13(19)2023 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37835892
3.
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
Microorganisms
; 11(10)2023 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37894265
4.
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients.
Viruses
; 15(5)2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243208